EX-99 2 ex99.htm PRESS RELEASE DATED MARCH 31, 2009 ex99.htm
Exhibit 99
 
 
For Immediate Release

National Patent Development Corporation Reports Year End Operating Results

NEW YORK, March 31, 2009--National Patent Development Corporation (OTC Bulletin Board: NPDV.OB - News) today reported a net loss of $(3,394,000), $(0.20) per basic share, for the year ended December 31, 2008, compared to net income of $11,722,000, or $0.67 per basic and  diluted share, for the year ended December 31, 2007.

The results for the year ended December 31, 2008 include a charge of $1,096,000 related to the resignation of the former Chairman of the Board of its wholly owned subsidiary, Five Star Products, Inc. (“Five Star”) on March 25, 2008 and $489,000 of previously unrecognized compensation cost related to unvested share-based compensation arrangements of Five Star being charged to operations. The results for the year ended December 31, 2007 include a gain of $17,031,000 recognized as a result of the sale of the Company’s ownership interest in Indevus Pharmaceuticals, Inc which it received as a result of the merger of Valera Pharmaceuticals, Inc. into Indevus, including the receipt, in May 2007, of an additional payment based upon the attainment of a post-merger milestone.  The Company’s operating loss excluding the items set forth above for the year ended December 31 was $(1,720,000) in 2008 and $(762,000) in 2007.

The increase in adjusted operating loss was primarily attributable to the decline in operating profits of Five Star, National Patent's wholly owned subsidiary, during 2008 due to the overall weakness in the economy and its marketplace. Harvey Eisen, the Company’s CEO, said, “Five Star’s disappointing results reflect the current extraordinary market conditions.  During this period, Five Star will continue its disciplined focus on managing working capital, margin and expenses. The Company has reacted quickly and effectively to deal with the current adverse environment and to protect itself from future challenges.”
 
 
About National Patent Development Corporation
 
 
National Patent Development Corporation (OTC Bulletin Board: NPDV.OB - News), is the owner of Five Star. Five Star is engaged in the wholesale distribution of paint sundry and hardware products in the Northeast and Middle-Atlantic states with particular strength in the greater New York metropolitan area. The Company distributes products to approximately 3,000 independent retail dealers, which include paint stores, independent hardware stores, lumber yards, and do-it yourself centers. The Company distributes a range of private label products sold under the "Five Star" name. Five Star operates two distribution centers, the primary one located in East Hanover, NJ and another in Newington, CT.   In addition, National Patent owns certain non-core assets including real estate.
 

 
Safe Harbor Statement
 
This press release contains certain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the U.S. Private Securities Litigation Reform Act of 1995, including statements relating to, among other things, future business plans, strategies and financial position, working capital and capital expenditure needs, and any statements of belief and any statements of assumptions underlying any of the foregoing.
 
These forward-looking statements reflect the current view of the management of National Patent Development Corporation with respect to future events and financial performance and are subject to certain risks, uncertainties, assumptions and changes in condition that could cause actual results to differ materially from those in the forward-looking statements, all of which are difficult to predict and many of which are beyond the control of National Patent Development Corporation, including, but not limited to the risks, uncertainties, assumptions and changes in condition detailed National Patents' periodic reports and registration statements filed with the Securities and Exchange Commission.
 
National Patent Development Corporation does not intend to, and disclaims any duty or obligation to, update or revise any forward-looking statements or industry information set forth in this press release to reflect new information, future events or otherwise, except as required by law.
 
Contact:
National Patent Development Corporation
John Belknap, 973-428-4600 (x167)
 
Tables Follow:
 
 
 
 

 
 NATIONAL PATENT DEVELOPMENT CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS DATA
(in thousands, except per share data)
 
 
   
Year Ended
 
   
December 31,
 
   
2008
   
2007
 
             
Sales
  $ 115,461     $ 123,713  
Cost of sales
    95,133       102,246  
Gross margin
    20,328       21,467  
                 
Selling, general and administrative
  expenses
    (22,537 )     (22,229 )
Charge related to resignation of Chairman of Five Star
    (1,096 )        
                 
      Operating  loss
    (3,305 )     (762 )
                 
Interest expense
    (1,366 )     (1,429 )
Gain on exchange of Valera for Indevus shares
    -       17,031  
Investment and other income (loss), net
    94       (1,605 )
                 
(Loss) income from continuing operations before income taxes and  minority interest
    (4,577 )     13,235  
                 
Income tax benefit (expense)
    940       (1,269 )
                 
(Loss) income from continuing operations before minority interest
    (3,637 )     11,966  
                 
Minority interest
    (34 )     (514 )
                 
(Loss) income from continuing operations
    (3,671 )     11,452  
                 
Income from discontinued operations, net of taxes, including an $87 gain on sale of
assets in 2008
    277       270  
                 
Net (loss) income
  $ (3,394 )   $ 11,722  
                 
Basic and diluted net (loss) income per share:
               
       Continuing operations
  $ (0.22 )   $ 0.65  
       Discontinued operations
    0.02       0.02  
       Net (loss) income per share
  $ (0.20 )   $ 0.67  


 
NATIONAL PATENT DEVELOPMENT CORPORATION
CONSOLIDATED BALANCE SHEETS DATA
(in thousands, except share and per share data)

   
December 31,
 
   
2008
   
2007
 
Assets
           
Current assets
           
Cash and cash equivalents
 
$
13,089
   
$
15,698
 
Accounts and other receivables, less allowance for doubtful accounts of $420 and $271
   
9,814
     
12,755
 
Inventories
   
23,045
     
27,720
 
Deferred tax asset
   
132
     
470
 
Prepaid expenses and other current assets
   
1,334
     
1,326
 
Total current assets
   
47,414
     
57,969
 
Marketable securities available for sale
   
7
     
109
 
Property, plant and equipment, net
   
912
     
3,534
 
Intangible assets, net
   
599
         
Deferred tax asset
   
1,537
         
Other assets
   
3,202
     
3,293
 
Total assets
 
$
53,671
   
$
64,905
 
                 
Liabilities and stockholders’ equity
               
Current liabilities
               
Current maturities of long-term debt
 
$
     
$
257
 
Short term borrowings
   
18,375
     
19,928
 
Accounts payable and accrued expenses
   
8,236
     
13,530
 
Total current liabilities
   
26,611
     
33,715
 
Long-term debt less current maturities
           
1,441
 
Deferred tax liability
           
279
 
Liability related to interest rate swap
   
1,111 
         
Minority interest
           
2,902
 
Common stock subject to exchange rights
           
493
 
                 
Commitments and contingencies
               
                 
Stockholders’ equity
               
Preferred stock, par value $0.01 per share authorized 10,000,000 shares;
  issued none
   
-
     
-
 
Common stock, par value $0.01 per share authorized 30,000,000 shares;
  issued 18,105,148 shares in 2008 and 18,086,006 shares in 2007
   
181
     
180
 
Additional paid-in capital
   
28,642
     
26,825
 
Retained earnings (deficit)
   
(849
)
   
2,545
 
Treasury stock, at cost (564,569 shares in 2008 and 1,528,462 shares in 2007)
   
(1,358
)
   
(3,458
)
Accumulated other comprehensive (loss) income
   
(667
)
   
(17
)
Total stockholders’ equity
   
25,949
     
26,075
 
Total liabilities and stockholders’ equity
 
$
53,671
   
$
64,905